Frontlight ResearchEarly access
Trial site
Chelyabinsk
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease2 trials
- Metastatic breast cancer2 trials
- Stroke2 trials
- Gastric and oesophageal cancer1 trial
- Hidradenitis suppurativa1 trial
- Melanoma1 trial
- Psoriasis1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 36 trials
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals9 trials
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis
Active, not recruiting
Closed trials
Terminated
Completed
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026